242 related articles for article (PubMed ID: 30911658)
1. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in combination with standard of care chemotherapy in primarily untreated chemo naïve upper gi-adenocarcinomas with peritoneal seeding - a phase II/III trial of the AIO/CAOGI/ACO.
Oliver Goetze T; Al-Batran SE; Pabst U; Reymond M; Tempfer C; Bechstein WO; Bankstahl U; Gockel I; Königsrainer A; Kraus T; Mönig SP; Rau B; Schwarzbach M; Piso P
Pleura Peritoneum; 2018 Jun; 3(2):20180113. PubMed ID: 30911658
[TBL] [Abstract][Full Text] [Related]
2. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in multimodal therapy for patients with oligometastatic peritoneal gastric cancer: a randomized multicenter phase III trial PIPAC VEROne.
Casella F; Bencivenga M; Rosati R; Fumagalli UR; Marrelli D; Pacelli F; Macrì A; Donini A; Torroni L; Pavarana M; De Manzoni G
Pleura Peritoneum; 2022 Sep; 7(3):135-141. PubMed ID: 36159218
[TBL] [Abstract][Full Text] [Related]
3. Phase I/II study of oxaliplatin dose escalation via a laparoscopic approach using pressurized aerosol intraperitoneal chemotherapy (PIPOX trial) for nonresectable peritoneal metastases of digestive cancers (stomach, small bowel and colorectal): Rationale and design.
Dumont F; Senellart H; Pein F; Campion L; Glehen O; Goere D; Pocard M; Thibaudeau E
Pleura Peritoneum; 2018 Sep; 3(3):20180120. PubMed ID: 30911664
[TBL] [Abstract][Full Text] [Related]
4. PIPAC EstoK 01: Pressurized IntraPeritoneal Aerosol Chemotherapy with cisplatin and doxorubicin (PIPAC C/D) in gastric peritoneal metastasis: a randomized and multicenter phase II study.
Eveno C; Jouvin I; Pocard M
Pleura Peritoneum; 2018 Jun; 3(2):20180116. PubMed ID: 30911659
[TBL] [Abstract][Full Text] [Related]
5. Randomized control trial comparing quality of life of patients with end-stage peritoneal metastasis treated with pressurized intraperitoneal aerosol chemotherapy (PIPAC) and intravenous chemotherapy.
Somashekhar SP; Ashwin KR; Rauthan CA; Rohit KC
Pleura Peritoneum; 2018 Sep; 3(3):20180110. PubMed ID: 30911661
[TBL] [Abstract][Full Text] [Related]
6. Initial experience of pressurized intraperitoneal aerosol chemotherapy (PIPAC) in a French hyperthermic intraperitoneal chemotherapy (HIPEC) expert center.
Ceribelli C; Debs T; Chevallier A; Piche MA; Bereder JM
Surg Endosc; 2020 Jun; 34(6):2803-2806. PubMed ID: 32166545
[TBL] [Abstract][Full Text] [Related]
7. PIPAC-OV3: A multicenter, open-label, randomized, two-arm phase III trial of the effect on progression-free survival of cisplatin and doxorubicin as Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC) vs. chemotherapy alone in patients with platinum-resistant recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer.
Bakrin N; Tempfer C; Scambia G; De Simone M; Gabriel B; Grischke EM; Rau B
Pleura Peritoneum; 2018 Sep; 3(3):20180114. PubMed ID: 30911662
[TBL] [Abstract][Full Text] [Related]
8. Unresectable peritoneal metastasis treated by pressurized intraperitoneal aerosol chemotherapy (PIPAC) leading to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Alyami M; Mercier F; Siebert M; Bonnot PE; Laplace N; Villeneuve L; Passot G; Glehen O; Bakrin N; Kepenekian V
Eur J Surg Oncol; 2021 Jan; 47(1):128-133. PubMed ID: 31253545
[TBL] [Abstract][Full Text] [Related]
9. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) as a neoadjuvant therapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Girshally R; Demtröder C; Albayrak N; Zieren J; Tempfer C; Reymond MA
World J Surg Oncol; 2016 Sep; 14(1):253. PubMed ID: 27678344
[TBL] [Abstract][Full Text] [Related]
10. Pressurized IntraPeritoneal Aerosol Chemotherapy vs. intravenous chemotherapy for unresectable peritoneal metastases secondary to platinum resistant ovarian cancer - study protocol for a randomized control trial.
Somashekhar SP; Ashwin KR; Rauthan A; Rohit KC
Pleura Peritoneum; 2019 Mar; 4(1):20180111. PubMed ID: 31198851
[TBL] [Abstract][Full Text] [Related]
11. Multicenter dose-escalation Phase I trial of mitomycin C pressurized intraperitoneal aerosolized chemotherapy in combination with systemic chemotherapy for appendiceal and colorectal peritoneal metastases: rationale and design.
Raoof M; Sullivan KM; Frankel PH; Fakih M; Synold TW; Lim D; Woo Y; Paz IB; Fong Y; Thomas RM; Chang S; Eng M; Tinsley R; Whelan RL; Deperalta D; Reymond MA; Jones J; Merchea A; Dellinger TH
Pleura Peritoneum; 2022 Dec; 7(4):169-177. PubMed ID: 36560966
[TBL] [Abstract][Full Text] [Related]
12. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in patients with peritoneal surface malignancies (PSM): a prospective single-center registry study.
Jansen-Winkeln B; Eberth J; Moulla Y; Mehdorn M; Niebisch S; Schierle K; Bläker H; Lordick F; Gockel I; Thieme R
J Cancer Res Clin Oncol; 2023 Mar; 149(3):1331-1341. PubMed ID: 36513815
[TBL] [Abstract][Full Text] [Related]
13. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy versus palliative systemic chemotherapy in stomach cancer patients with peritoneal dissemination, the study protocol of a multicentre randomised controlled trial (PERISCOPE II).
Koemans WJ; van der Kaaij RT; Boot H; Buffart T; Veenhof AAFA; Hartemink KJ; Grootscholten C; Snaebjornsson P; Retel VP; van Tinteren H; Vanhoutvin S; van der Noort V; Houwink A; Hahn C; Huitema ADR; Lahaye M; Los M; van den Barselaar P; Imhof O; Aalbers A; van Dam GM; van Etten B; Wijnhoven BPL; Luyer MDP; Boerma D; van Sandick JW
BMC Cancer; 2019 May; 19(1):420. PubMed ID: 31060544
[TBL] [Abstract][Full Text] [Related]
14. Systemic chemotherapy and pressurized intraperitoneal aerosol chemotherapy (PIPAC): A bidirectional approach for gastric cancer peritoneal metastasis.
Di Giorgio A; Schena CA; El Halabieh MA; Abatini C; Vita E; Strippoli A; Inzani F; Rodolfino E; Romanò B; Pacelli F; Rotolo S
Surg Oncol; 2020 Sep; 34():270-275. PubMed ID: 32891341
[TBL] [Abstract][Full Text] [Related]
15. Bidirectional chemotherapy in gastric cancer with peritoneal metastasis combining intravenous XELOX with intraperitoneal chemotherapy with low-dose cisplatin and Doxorubicin administered as a pressurized aerosol: an open-label, Phase-2 study (PIPAC-GA2).
Khomyakov V; Ryabov A; Ivanov A; Bolotina L; Utkina A; Volchenko N; Kaprin A
Pleura Peritoneum; 2016 Sep; 1(3):159-166. PubMed ID: 30911619
[No Abstract] [Full Text] [Related]
16. Surgical Options for Peritoneal Surface Metastases from Digestive Malignancies-A Comprehensive Review.
Eftimie MA; Potlog G; Alexandrescu ST
Medicina (Kaunas); 2023 Jan; 59(2):. PubMed ID: 36837456
[TBL] [Abstract][Full Text] [Related]
17. Is PIPAC a Treatment Option in Upper and Lower Gastrointestinal Cancer with Peritoneal Metastasis?
Guel-Klein S; Alberto Vilchez ME; Ceelen W; Rau B; Brandl A
Visc Med; 2022 Apr; 38(2):90-98. PubMed ID: 35614892
[TBL] [Abstract][Full Text] [Related]
18. Pressurized intraperitoneal aerosol chemotherapy with low-dose cisplatin and doxorubicin (PIPAC C/D) in patients with gastric cancer and peritoneal metastasis: a phase II study.
Struller F; Horvath P; Solass W; Weinreich FJ; Strumberg D; Kokkalis MK; Fischer I; Meisner C; Königsrainer A; Reymond MA
Ther Adv Med Oncol; 2019; 11():1758835919846402. PubMed ID: 31205501
[TBL] [Abstract][Full Text] [Related]
19. MESOTIP: Phase II multicenter randomized trial evaluating the association of PIPAC and systemic chemotherapy vs. systemic chemotherapy alone as 1st-line treatment of malignant peritoneal mesothelioma.
Sgarbura O; Gourgou S; Tosi D; Bakrin N; Bouazza N; Delaine S; De Forges H; Pocard M; Quénet F
Pleura Peritoneum; 2019 Jun; 4(2):20190010. PubMed ID: 31417958
[TBL] [Abstract][Full Text] [Related]
20. Practice patterns, attitudes, and knowledge among clinicians regarding hyperthermic intraperitoneal chemotherapy and pressurized intraperitoneal aerosol chemotherapy: a national survey by Indian society of peritoneal surface malignancies (ISPSM).
Somashekhar SP; Rohit KC; Deo SVS; Ashwin KR
Pleura Peritoneum; 2020 Sep; 5(3):20200120. PubMed ID: 33364340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
